Very high risk | High risk | Medium risk | Low risk | Abstinence | Death* | Serious events† | |
---|---|---|---|---|---|---|---|
Year 1 | |||||||
NMF | 0.18 | 0.17 | 0.12 | 0.40 | 0.10 | 0.01 | 0.02 |
PS | 0.26 | 0.27 | 0.14 | 0.22 | 0.08 | 0.01 | 0.02 |
Very high risk/high risk | Medium risk | Low risk/abstinence (controlled drinking state) | Death* | Serious events† | |||
Year 2 | |||||||
NMF | 0.38 | 0.07 | 0.50 | 0.01 | 0.04 | ||
PS | 0.56 | 0.07 | 0.30 | 0.02 | 0.04 | ||
Year 3 | |||||||
NMF | 0.40 | 0.04 | 0.47 | 0.02 | 0.06 | ||
PS | 0.58 | 0.05 | 0.28 | 0.02 | 0.07 | ||
Year 4 | |||||||
NMF | 0.42 | 0.03 | 0.44 | 0.03 | 0.07 | ||
PS | 0.60 | 0.03 | 0.25 | 0.03 | 0.09 | ||
Year 5 | |||||||
NMF | 0.44 | 0.03 | 0.40 | 0.04 | 0.09 | ||
PS | 0.60 | 0.02 | 0.22 | 0.04 | 0.11 |
*Absorbing state.
†Serious event state (‘post-event state’): Ischaemic heart disease; Haemorrhagic stroke; Ischaemic stroke; Cirrhosis of the liver; Pancreatitis.
NMF, nalmefene plus psychosocial support; PS, psychosocial support alone.